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Background
A high efficacy multi-stage multi-epitope malaria vac-
cine would be an invaluable weapon in the eradication
of malaria. Currently, the best progress in subunit vac-
cine research has been seen in targeting pre-erythrocytic
(PE) stages of the parasite. In phase IIa trials, RTS,S in
adjuvant was capable of inducing sterile protection in
50% of individuals [1], and ME-TRAP in a heterologous
prime-boost regime saw around 21% efficacy [2]. Here
we present a mathematical model investigating the
effects of combining these two approaches.
Materials and methods
A mathematical model was developed to describe Plas-
modium falciparum parasite dynamics within an immu-
nonaive host. The model was parameterised using data
from non-vaccine recipients in Controlled Human
Malaria Infection (CHMI) studies, and then used to
study the effects of vaccine induced immune responses
against the sporozoite and hepatocytic stages of the life
cycle, and the effects of combining them.
Results
Using data from phase IIa trials of RTS,S [1]and ME-
TRAP [2], we predict that near total sterile protection can
be achieved by combining these vaccines. Even very low
efficacy (<1%) vaccines are shown to combine to confer
sterile protection in up to 43% of individuals.
Conclusions
We find a heterologous vaccine treatment to act syner-
gistically: the efficacy of the combination far outweighs
the sum of its parts. This suggests that a high efficacy
multi-stage vaccine may well be within reach, and may
utilise some of the tools presently available.
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